Middle East & Africa Biopharmaceutical Cro Market Size & Outlook

Name: Middle East & Africa Biopharmaceutical Cro Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The biopharmaceutical cro market in Middle East & Africa is expected to reach a projected revenue of US$ 3,171.5 million by 2033. A compound annual growth rate of 8.1% is expected of Middle East & Africa biopharmaceutical cro market from 2025 to 2033.

Middle East & Africa biopharmaceutical cro type outlook (Revenue, USD million, 2021-2033)
- Drug Discovery
  - Target Validation
  - Lead Identification
  - Lead Optimization
- Pre-Clinical
- Clinical
  - Phase I Trial Services
  - Phase II Trial Services
  - Phase III Trial Services
  - Phase IV Trial Services
Middle East & Africa biopharmaceutical cro product outlook (Revenue, USD million, 2021-2033)
- Monoclonal antibodies (mAbs)
- Recombinant proteins & enzymes
- Vaccines
- Cell & Gene Therapies
- Nucleic acid Therapeutics
- Others
Middle East & Africa biopharmaceutical cro service outlook (Revenue, USD million, 2021-2033)
- Project Management/Clinical Supply Management
- Data Management
- Regulatory/Medical Affairs
- Medical Writing
- Clinical Monitoring
- Quality Management/ Assurance
- Bio-statistics
- Investigator Payments
- Laboratory
- Patient And Site Recruitment
- Technology
- Others
Middle East & Africa biopharmaceutical cro therapeutic area outlook (Revenue, USD million, 2021-2033)
- Oncology
- CNS Disorders
- Infectious Diseases
- Immunological Disorders
- Cardiovascular Disease
- Respiratory Diseases
- Diabetes
- Ophthalmology
- Pain Management
- Others
Middle East & Africa biopharmaceutical cro end use outlook (Revenue, USD million, 2021-2033)
- Large Pharmaceutical & Biotechnology companies
- Small & Mid-Size Sponsors
- Academic & Government research

Middle East & Africa Biopharmaceutical Cro Market Size & Outlook

Sign up - it's easy, and free!